PLSE
Pulse Biosciences Inc
NASDAQ: PLSE · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$21.17
+4.75% today
Updated 2026-04-30
Market cap
$1.48B
P/E ratio
—
P/S ratio
4,240.58x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$13 – $26
Volume
0.3M
Pulse Biosciences Inc (PLSE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-173143.00 | $-3.32M | $-8.05M | $-11.09M | $-23.90M | $-34.19M | $-35.37M | $-54.10M | $-47.01M | $-33.04M | $-36.34M | $-54.12M |
| Capital expenditures | $78857.00 | $86030.00 | $64000.00 | $2.55M | $276000.00 | $608000.00 | $441000.00 | $437000.00 | $401000.00 | $121000.00 | $125000.00 | $315000.00 |
| Depreciation | $200571.00 | $716984.00 | $759000.00 | $1.00M | $1.31M | $1.16M | $1.09M | $1.15M | $1.35M | $1.21M | $1.18M | $1.07M |
| Stock-based comp | — | $402092.00 | $870000.00 | $10.93M | $12.34M | $11.29M | $10.07M | $14.60M | $5.19M | $7.18M | $13.59M | $21.46M |
| Free cash flow | $-252000.00 | $-3.40M | $-8.12M | $-13.64M | $-24.17M | $-34.79M | $-35.81M | $-54.53M | $-47.41M | $-33.16M | $-36.47M | $-54.44M |
| Investing cash flow | $-77143.00 | $-86030.00 | $-14.38M | $-23.00M | $26.12M | $-10.10M | $10.04M | $7.56M | $-401000.00 | $-121000.00 | $-125000.00 | $-335000.00 |
| Financing cash flow | $12.27M | $20.91M | $20.91M | $35.38M | $45.50M | $82000.00 | $30.89M | $62.69M | $79.94M | $16.39M | $110.14M | $17.15M |
| Dividends paid | — | — | $0.00 | $0.00 | — | $619000.00 | — | $810000.00 | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-1.52M | $1.30M | $47.72M | $-44.20M | $5.56M | — | — | — | — | — |